News


Untangling Amyloidosis Symposium

Untangling Amyloidosis Symposium

Here are the individual speakers from the “Untangling Amyloidosis” Symposium at the 60th ASH (American Society of Hematology) Conference in November, 2018. The Amyloidosis Foundation was proud to support Junior Researcher Travel Grants for this event. Click below to listen to each topic.

Welcome Message

 

Initial Therapy of AL Amyloidosis in Transplant-Eligible and -Ineligible Patients
Giovanni Palladini, MD, PhD
Acting Director, Amyloidosis Research & Treatment Center
University of Pavia Pavia, Italy

Watch Here

 

 

Incorporating Monoclonal Antibodies into Anti-Plasma Cell Regimens in AL Amyloidosis
Suzanne Lentzsch, MD, PhD
Director, Multiple Myeloma and Amyloidosis Service
Columbia University Medical CenterNew York City, USA

Watch Here

 

 

The Evidence for Use of Doxycycline as Adjunctive Therapy for Cardiac Amyloidosis
Prof. Ashutosh Wechalekar
Professor of Medicine and Haematology
University
College London

Watch Here

 

 

Protein- and Fibril-Directed Therapies in AL Amyloidosis
Jeffrey Zonder, MD
Leader, Myeloma and Amyloidosis Program
Karmanos Cancer Institute/Wayne State University
Detroit, USA

Watch Here

 

 

Gene Silencing Therapies in ATTR Amyloidosis
Sascha Tuchman, MD MHS
Director, Multiple Myeloma and Amyloidosis Program
University of North Carolina Lineberger Comprehensive Cancer Center
Chapel Hill, NC

Watch Here

 

 

Developing New Therapies for Amyloidosis in a Complex Research Landscape
John Berk, MD
Assistant Director, Amyloidosis Center
Boston University School of Medicine
Boston, USA

Watch Here

Panel Discussion / Q+A (All Speakers)